SCHEMBL21423913

SCHEMBL21423913

NC1CC(C(=O)NI)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23936853 0.81 ULK1 (0.41)
SCHEMBL23936791 0.81 ULK1 (0.41)
SCHEMBL19245766 0.77
SCHEMBL18460603 0.77
SCHEMBL31334842 0.75
SCHEMBL21028379 0.75
SCHEMBL16127204 0.75
SCHEMBL22916922 0.73
Hydrochloric Acid SCHEMBL29625162 0.73 CHRNB2 (0.52)
SCHEMBL13476038 0.73 HDAC8 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3475277-B1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF BIOIMICS AB (SE) 2021-10-20 EP disclosed
WO-2020215022-A1 NOVEL COMPOUNDS AND METHODS OF USE TREATING FRUCTOSE-RELATED DISORDERS OR DISEASES COLORADO RESEARCH PARTNERS, LLC (US) 2020-10-22 WO disclosed
WO-2019189778-A1 COMPOUND WITH ANTICANCER ACTIVITY 協和発酵キリン株式会社 2019-10-03 WO disclosed